<p><b>(A) Receiver operator characteristic (ROC) analysis for serum metabolites, cardiac peptides, and combined serum metabolites and BNP.</b> Logistic regression (LR) was performed to find the most parsimonious model to discriminate HFpEF from HFrEF patients using the minimum number of metabolites and/or cardiac peptides. 2-hydroxybutyrate, octadecenoylcarnitine (C18:1), hydroxyprionylcarnitine (C3-OH), and sphingomyelin C24:1 were used in the metabolites-only panel. While acetate, 2-hydroxybutyrate, pimelyl carnitine, and phosphatidyl choline diacyl C40:4 were used for the combined metabolites and NT-proBNP panel. <b>(B–E) Quantification of the metabolites used to derive the LR equation of the combined metabolites and NT-proBNP model.</b>...
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the...
AbstractBackgroundIdentification of novel biomarkers is needed to improve the diagnosis and prognosi...
In this study, urinary metabolic profiles of patients with heart failure (HF) and healthy individual...
<p><b>(A) Receiver operator characteristic (ROC) analysis for serum metabolites, cardiac peptides, a...
<p><b>(A) Receiver operator characteristic (ROC) analysis for serum metabolites, cardiac peptides, a...
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an importa...
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an importa...
Heart failure (HF) is characterized by a series of maladaptive metabolic changes, which have recentl...
Background: Measurement of small molecules of intermediary metabolism is a method for characterizing...
A variety of atherosclerosis and cardiovascular disease (ASCVD) phenotypes are tightly linked to cha...
<p>Ambulatory patients with clinical diagnosis of HFpEF (n = 24), HFrEF (n = 20), and age-matched co...
This study sought to derive and validate plasma metabolite associations with survival in heart failu...
Background: Measurement of small molecules of intermediary metabolism (‘metabolites’) is an emerging...
The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure bio...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the...
AbstractBackgroundIdentification of novel biomarkers is needed to improve the diagnosis and prognosi...
In this study, urinary metabolic profiles of patients with heart failure (HF) and healthy individual...
<p><b>(A) Receiver operator characteristic (ROC) analysis for serum metabolites, cardiac peptides, a...
<p><b>(A) Receiver operator characteristic (ROC) analysis for serum metabolites, cardiac peptides, a...
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an importa...
Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an importa...
Heart failure (HF) is characterized by a series of maladaptive metabolic changes, which have recentl...
Background: Measurement of small molecules of intermediary metabolism is a method for characterizing...
A variety of atherosclerosis and cardiovascular disease (ASCVD) phenotypes are tightly linked to cha...
<p>Ambulatory patients with clinical diagnosis of HFpEF (n = 24), HFrEF (n = 20), and age-matched co...
This study sought to derive and validate plasma metabolite associations with survival in heart failu...
Background: Measurement of small molecules of intermediary metabolism (‘metabolites’) is an emerging...
The metabolic changes that accompany changes in Cardiopulmonary testing (CPET) and heart failure bio...
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and ...
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the...
AbstractBackgroundIdentification of novel biomarkers is needed to improve the diagnosis and prognosi...
In this study, urinary metabolic profiles of patients with heart failure (HF) and healthy individual...